You know its bad when even Martin Shkreli is accusing you of price gauging for needed medical goods. The pharma bro who jacked up the price of a drug 5,000 percent overnight and planned other mass drug hikes at Kalobios before he was removed, has called out Mylan Inc. (NASDAQ:MYL) for jacking up the price of Epipen. Shkreli told NBC: “Amazing that Epipen prices in CA & EU with prescription are about $85,” said one of the many consumers who were immediately on the Internet to register their disgust at Mylan. “No (government) negotiated buy in US.” Another accused the…